Cargando…
BMI-1 is a potential therapeutic target in diffuse intrinsic pontine glioma
Diffuse intrinsic pontine glioma (DIPG) is a poor-prognosis pediatric brain tumor. No effective curative therapy is currently available and no therapeutic advances have been made in several decades. BMI-1 is a member of the multimeric protein complex Polycomb repressor complex 1. It is highly expres...
Autores principales: | Kumar, Shiva Senthil, Sengupta, Satarupa, Lee, Kyungwoo, Hura, Nanki, Fuller, Christine, DeWire, Mariko, Stevenson, Charles B., Fouladi, Maryam, Drissi, Rachid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609895/ https://www.ncbi.nlm.nih.gov/pubmed/28968963 http://dx.doi.org/10.18632/oncotarget.18002 |
Ejemplares similares
-
DIPG-21. INDUCTION OF MITOTIC ABNORMALITIES AND BMI-1 MODULATION TO TREAT DIFFUSE INTRINSIC PONTINE GLIOMA
por: Kumar, Shiva Senthil, et al.
Publicado: (2020) -
EPID-15. THE INTERNATIONAL DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)/DIFFUSE MIDLINE GLIOMA (DMG) REGISTRY AND REPOSITORY (IDIPGR) EXPANSION
por: Torontali, Marianne, et al.
Publicado: (2020) -
Spatial genomic heterogeneity in diffuse intrinsic pontine and midline high-grade glioma: implications for diagnostic biopsy and targeted therapeutics
por: Hoffman, Lindsey M., et al.
Publicado: (2016) -
Erratum: Spatial genomic heterogeneity in diffuse intrinsic pontine and midline high-grade glioma: implications for diagnostic biopsy and targeted therapeutics
por: Hoffman, Lindsey M., et al.
Publicado: (2016) -
EPCT-19. A PHASE I STUDY OF RIBOCICLIB AND EVEROLIMUS FOLLOWING RADIATION THERAPY IN CHILDREN WITH NEWLY DIAGNOSED NON-BIOPSIED DIFFUSE PONTINE GLIOMAS (DIPG) AND RB+ BIOPSIED DIPG AND HIGH GRADE GLIOMAS (HGG)
por: DeWire, Mariko, et al.
Publicado: (2020)